45, X/46, XY mosaicism and gender incongruence: ethical, medical, and psychological considerations
-
Charlotte Horrigan
Abstract
Objectives
45, X/46, XY mosaicism is a complex chromosomal difference of sexual development, commonly associated with 45, X/46, XY karyotype. It presents a broad phenotypic spectrum, creating challenges in gender assignment. This report examines the management of a child with 45, X/46, XY mosaicism diagnosed in middle childhood, assigned female at birth but later exhibiting gender incongruence, highlighting dilemmas in pubertal induction after prophylactic gonadectomy.
Case presentation
An 8-year-old female presented with differences in sexual development (DSD) following maternal concerns regarding genital appearance. Genetic investigations confirmed a 45, X/46, XY karyotype, leading to bilateral gonadectomy due to malignancy risk. By age 11, the child expressed alignment with being a boy while reluctantly being perceived as a girl. The absence of endogenous sex hormones following gonadectomy will complicate pubertal induction as there is incongruency between the child’s gender preference and the sex of rearing.
Conclusions
Limited guidance exists on managing gender incongruence in DSD, particularly regarding pubertal induction. In the UK, while sex assignment at birth is mandated, there is no specific guidance regarding the revision of sex assignment in childhood. A non-coercive environment is essential to support gender exploration whilst balancing medical, psychological, and ethical considerations in decision-making regarding pubertal induction.
-
Research ethics: Not applicable.
-
Informed consent: Informed consent was obtained from all individuals included in this study, or their legal guardians or wards.
-
Author contributions: Dr. Horrigan drafted the initial manuscript and reviewed and revised the manuscript. Dr. Giri, Dr. Alderson contributed to patient care, reviewed and revised the manuscript. Dr. Giri, Dr. Park and Dr. Alderson reviewed and revised the manuscript. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
-
Use of Large Language Models, AI and Machine Learning Tools: None declared.
-
Conflict of interest: The authors state no conflict of interest.
-
Research funding: None declared.
-
Data availability: Not applicable.
References
1. Stochholm, K, Holmgard, C, Davis, SM, Gravholt, CH, Berglund, A. Incidence, prevalence, age at diagnosis, and mortality in individuals with 45,X/46,XY mosaicism: a population-based registry study. Genet Med 2024;26:100987.10.1016/j.gim.2023.100987Search in Google Scholar PubMed
2. Ahmed, SF, Achermann, JC, Arlt, W, Balen, A, Conway, G, Edwards, Z, et al.. Society for Endocrinology UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development (Revised 2015). Clinical Endocrinology 2016;84:771–88.10.1111/cen.12857Search in Google Scholar PubMed PubMed Central
3. Hughes, IA, Houk, C, Ahmed, SF, Lee, PA, LWPES Consensus Group, ESPE Consensus Group. Consensus statement on management of intersex disorders. Arch Dis Child 2006;91:554–63.10.1136/adc.2006.098319Search in Google Scholar PubMed PubMed Central
4. UK. Standards for Paediatric Endocrinology, January 2019 [Online]. Available from: https://www.rcpch.ac.uk/sites/default/files/2019-01/uk_paediatric_endocrine_standards_-_january_2019_-_final_0.pdf.Search in Google Scholar
5. Hembree, WC, Cohen-Kettenis, PT, Gooren, L, Hannema, SE, Meyer, WJ, Murad, MH, et al.. Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2017;102:3869–903.10.1210/jc.2017-01658Search in Google Scholar PubMed
6. Yates, AP, Jopling, HM, Burgoyne, NJ, Hayden, K, Chaloner, CM, Tetlow, L. Paediatric reference intervals for plasma anti-Müllerian hormone: comparison of data from the Roche Elecsys assay and the Beckman Coulter access assay using the same cohort of samples. Ann Clin Biochem 2019;56:536–47.10.1177/0004563219830733Search in Google Scholar PubMed PubMed Central
7. Lee, PA, Nordenström, A, Houk, CP, Ahmed, SF, Auchus, R, Baratz, A, et al., Global DSD Update Consortium. Global disorders of sex development update since 2006: perceptions, approach and care. Horm Res Paediatr 2016;85:158–80.10.1159/000442975Search in Google Scholar PubMed
8. Johansen, ML, Hagen, CP, Mieritz, MG, Petersen, JH, Mouritsen, A, Aksglaede, L, et al.. Clinical characteristics and long-term outcomes in 45,X/46,XY mixed gonadal dysgenesis. J Clin Endocrinol Metab 2012;97:E473–9.Search in Google Scholar
9. Matthews, D, Hindmarsh, P, Freemantle, N. Impact of delayed puberty on adolescent growth and development. Horm Res Paediatr 2017;88:224–35.Search in Google Scholar
10. Cass, H. Review of gender identity services for children and young people. BMJ 2022;376:o629.10.1136/bmj.o629Search in Google Scholar
11. Steensma, TD, Biemond, R, de Boer, F, Cohen-Kettenis, PT. Desisting and persisting gender dysphoria after childhood: a qualitative follow-up study. J Am Acad Child Adolesc Psychiatry 2013;52:582–90.10.1016/j.jaac.2013.03.016Search in Google Scholar PubMed
12. Zucker, KJ, Bradley, SJ, Owen-Anderson, A, Kibblewhite, SJ, Cantor, JM, Blanchard, R. Gender identity and sexual orientation outcomes in gender-dysphoric children. J Sex Marital Ther 2012;38:364–83.Search in Google Scholar
13. Meyer-Bahlburg, HF, Khuri, J, Reyes-Portillo, JA, Newcorn, JH. Gender dysphoria and its management in children and adolescents. J Clin Psychol Med Settings 2016;23:198–209.Search in Google Scholar
14. Turban, JL, Keuroghlian, AS, Reisner, SL. Association between gender-affirming hormones and mental health outcomes. JAMA Surg 2020;155:589–98.Search in Google Scholar
15. de Vries, AL, Steensma, TD, Doreleijers, TA, Cohen-Kettenis, PT. Puberty suppression in adolescents with gender identity disorder: a prospective follow-up study. J Sex Med 2014;11:1–9.Search in Google Scholar
16. Hines, M. Gender development and child psychopathology: the interaction of biological, social, and environmental influences. Curr Opin Psychol 2019;27:76–81.Search in Google Scholar
17. Guss, JD, Williams, DN, Reisner, SL, Austin, SB, Katz-Wise, SL. Impact of gender-affirming hormone therapy on bone mineral density in transgender individuals. J Clin Endocrinol Metab 2016;101:2429–34.Search in Google Scholar
18. Baxendale, S. The impact of suppressing puberty on neuropsychological function: a review. Acta Paediatr 2024;113:1156–67.10.1111/apa.17150Search in Google Scholar PubMed
© 2025 Walter de Gruyter GmbH, Berlin/Boston
